Drug Shortage Report for APO-ATORVASTATIN

Last updated on 2017-04-04 History
Report ID 709
Drug Identification Number 02295261
Brand name APO-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10
Estimated end date 2017-03-24
Actual end date 2017-03-22
Shortage status Resolved
Updated date 2017-04-04
Company comments APO-ATORVASTATIN FCT 10MG 90BTL CHLD-RES are available
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2017-04-04 French Compare
v15 2017-04-04 English Compare
v14 2017-03-23 English Compare
v13 2017-03-22 French Compare
v12 2017-03-22 English Compare
v11 2017-03-20 French Compare
v10 2017-03-20 English Compare
v9 2017-03-17 French Compare
v8 2017-03-17 English Compare
v7 2017-03-17 English Compare
v6 2017-03-17 English Compare
v5 2017-03-17 English Compare
v4 2017-03-17 French Compare
v3 2017-03-17 English Compare
v2 2017-03-12 French Compare
v1 2017-03-12 English Compare